You are here

Zymergen

Q3 2022: Layoffs Continue, Alzheimer’s Soars and Accelerated Approvals Fall

BioSpace

Mon, 10/3/22 - 11:33 pm

Vesalius Therapeutics

Bristol Myers Squibb

Zymergen Cuts 80 More Jobs, Parts Ways with Co-Founder

BioSpace

Fri, 08/26/22 - 10:39 am

7 months after announcing a pivot to drug discovery, Zymergen is acquired by Ginkgo

Fierce Biotech

Mon, 07/25/22 - 10:52 am

Ginkgo Bioworks

End-of-Year Restructuring Means Layoffs for These Companies

BioSpace

Tue, 11/16/21 - 11:57 am

Rigel Pharmaceuticals

Esperion Therapeutics

Acorda Therapeutics

Ziopharm Oncology

Zymergen's sudden implosion shocked biotech. A lingering loan could make things even worse

Endpoints

Wed, 08/4/21 - 10:48 pm

The incubator that hatched a Jennifer Doudna CRISPR startup blueprints new 'destination for life science entrepreneurship'

EP Vantage

Tue, 05/11/21 - 11:02 am

Caribou Biosciences

Jennifer Doudna

This Is Why Zymergen's IPO Was a Huge Success

Motley Fool

Tue, 04/27/21 - 11:31 pm

synthetic biology